Mostrar o rexistro simple do ítem

dc.contributor.authorTrujillo-Rodriguez, M.
dc.contributor.authorMuñoz-Muela, E.
dc.contributor.authorSerna-Gallego, A.
dc.contributor.authorPraena-Fernández, J.M.
dc.contributor.authorPérez-Gómez, A.
dc.contributor.authorGasca-Capote, C.
dc.contributor.authorVitallé, J.
dc.contributor.authorPeraire, J.
dc.contributor.authorPalacios-Baena, Z.R.
dc.contributor.authorCabrera Alvargonzalez, Jorge julio
dc.contributor.authorRuiz-Mateos, E.
dc.contributor.authorPoveda López, Eva 
dc.contributor.authorLópez-Cortés, L.E.
dc.contributor.authorRull, A.
dc.contributor.authorGutierrez-Valencia, A.
dc.contributor.authorLópez-Cortés, L.F.
dc.date.accessioned2025-08-26T08:16:42Z
dc.date.available2025-08-26T08:16:42Z
dc.date.issued2022
dc.identifier.citationTrujillo-Rodriguez M, Muñoz-Muela E, Serna-Gallego A, Praena-Fernández JM, Pérez-Gómez A, Gasca-Capote C, et al. Clinical, laboratory data and inflammatory biomarkers at baseline as early discharge predictors in hospitalized SARS-CoV-2 infected patients. PLoS ONE. 2022;17(7 July).
dc.identifier.issn1932-6203
dc.identifier.otherhttps://portalcientifico.sergas.gal/documentos/62e5c25ee5f0e01a6a1cf5af*
dc.identifier.urihttp://hdl.handle.net/20.500.11940/20586
dc.description.abstractBackground The SARS-CoV-2 pandemic has overwhelmed hospital services due to the rapid transmission of the virus and its severity in a high percentage of cases. Having tools to predict which patients can be safely early discharged would help to improve this situation. Methods Patients confirmed as SARS-CoV-2 infection from four Spanish hospitals. Clinical, demographic, laboratory data and plasma samples were collected at admission. The patients were classified into mild and severe/critical groups according to 4-point ordinal categories based on oxygen therapy requirements. Logistic regression models were performed in mild patients with only clinical and routine laboratory parameters and adding plasma pro-inflammatory cytokine levels to predict both early discharge and worsening. Results 333 patients were included. At admission, 307 patients were classified as mild patients. Age, oxygen saturation, Lactate Dehydrogenase, D-dimers, neutrophil-lymphocyte ratio (NLR), and oral corticosteroids treatment were predictors of early discharge (area under curve (AUC), 0.786; sensitivity (SE) 68.5%; specificity (S), 74.5%; positive predictive value (PPV), 74.4%; and negative predictive value (NPV), 68.9%). When cytokines were included, lower interferon-?-inducible protein 10 and higher Interleukin 1 beta levels were associated with early discharge (AUC, 0.819; SE, 91.7%; S, 56.6%; PPV, 69.3%; and NPV, 86.5%). The model to predict worsening included male sex, oxygen saturation, no corticosteroids treatment, C-reactive protein and Nod-like receptor as independent factors (AUC, 0.903; SE, 97.1%; S, 68.8%; PPV, 30.4%; and NPV, 99.4%). The model was slightly improved by including the determinations of interleukine-8, Macrophage inflammatory protein-1 beta and soluble IL-2R? (CD25) (AUC, 0.952; SE, 97.1%; S, 98.1%; PPV, 82.7%; and NPV, 99.6%). Conclusions Clinical and routine laboratory data at admission strongly predict non-worsening during the first two weeks; therefore, these variables could help identify those patients who do not need a long hospitalization and improve hospital overcrowding. Determination of pro-inflammatory cytokines moderately improves these predictive capacities.en
dc.description.sponsorshipThis work was supported by Consejeria de Salud y Familia (research Project COVID-00052020 and Research Contract RH-0037-2020 to JV); Consejeria de Transformacion Economica, Industria, Conocimiento y Universidades (PY20/01276 to APG); Instituto de Salud Carlos III (CP19/ 00159 to AGV, CP19/00146 to AR, FI19/00304 to EMM, FI19/00083 to MCGC, a way to make Europe, and COV20/00698 to support COHVIDGS), Red Tematica de Investigacion Cooperativa en SIDA (RD16/0025/0020, RD16/0025/0006 and RD16/0025/0026), Fondos FEDER; Centro de Investigacion Biomedica en Red de Enfermedades Infecciosas-ISCIII (CB21/13/00020) Madrid, Spain. ERM was supported by the Spanish Research Council (CSIC). AR is also supported by a grant from IISPV through the project 2019/IISPV/05 (Boosting Young Talent), by GeSIDA through the III Premio para Jo ' venes Investigadores. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.en
dc.language.isoeng
dc.rightsAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.titleClinical, laboratory data and inflammatory biomarkers at baseline as early discharge predictors in hospitalized SARS-CoV-2 infected patients*
dc.typeArticleen
dc.authorsophosTrujillo-Rodriguez, L. F. M.
dc.authorsophosMuñoz-Muela, E.
dc.authorsophosSerna-Gallego, A.
dc.authorsophosPraena-Fernández, J. M.
dc.authorsophosPérez-Gómez, A.
dc.authorsophosGasca-Capote, C.
dc.authorsophosVitallé, J.
dc.authorsophosPeraire, J.
dc.authorsophosPalacios-Baena, Z. R.
dc.authorsophosCabrera, J. J.
dc.authorsophosRuiz-Mateos, E.
dc.authorsophosPoveda, E.
dc.authorsophosLópez-Cortés, L. E.
dc.authorsophosRull, A.
dc.authorsophosGutierrez-Valencia, A.
dc.authorsophosLópez, Cortés
dc.identifier.doi10.1371/journal.pone.0269875
dc.identifier.sophos62e5c25ee5f0e01a6a1cf5af
dc.issue.number7 July
dc.journal.titlePLoS ONE*
dc.relation.projectIDConsejeria de Salud y Familia [COVID-00052020, RH-0037-2020]; Consejeria de Transformacion Economica, Industria, Conocimiento y Universidades [PY20/01276]; Instituto de Salud Carlos III [CP19/00159, CP19/00146, FI19/00304, FI19/00083, COV20/00698]; Red Tematica de Investigacion Cooperativa en SIDA [RD16/0025/0020, RD16/0025/0006, RD16/0025/0026]; Fondos FEDER; Centro de Investigacion Biomedica en Red de Enfermedades Infecciosas-ISCIII Madrid, Spain [CB21/13/00020]; Spanish Research Council (CSIC); IISPV [2019/IISPV/05]; GeSIDA
dc.relation.publisherversionhttps://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0269875&type=printablees
dc.rights.accessRightsopenAccess
dc.subject.keywordAS Vigoes
dc.subject.keywordCHUVIes
dc.subject.keywordIISGSes
dc.typefidesArtículo Científico (incluye Original, Original breve, Revisión Sistemática y Meta-análisis)es
dc.typesophosArtículo Originales
dc.volume.number17


Ficheiros no ítem

Este ítem aparece na(s) seguinte(s) colección(s)

Mostrar o rexistro simple do ítem

Atribución 4.0 Internacional
A non ser que se indique outra cousa, a licenza do ítem descríbese comoAtribución 4.0 Internacional